Phaos Technology Holdings (Cayman) (POAS) Leases (2024 - 2025)

Phaos Technology Holdings (Cayman) posted quarterly Leases of $38905.0 for Q4 2025, down 60.56% on a QoQ basis from $98633.7 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Leases data on file, last reported at $38905.0 in Q4 2025.

  • For the quarter ending Q4 2025, Leases changed N/A year-over-year to $38905.0; the trailing twelve-month figure through Oct 2025 stood at $38905.0 (changed N/A YoY), and the FY2025 full-year result was $100993.0, down 37.65% from the prior year.
  • Leases for Q4 2025 stood at $38905.0, down from $98633.7 in the prior quarter.
  • Across five years, Leases topped out at $161969.5 in Q2 2024 and bottomed at $38905.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 73.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 396.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 155.20 Mn
10 Phaos Technology Holdings (Cayman) 6.83 Mn 6.73 Mn - 38,905.00

Historic Data

Download Data 🔒
DateValue
Oct 31, 2025 38,905.00
Apr 30, 2025 98,633.66
Apr 30, 2024 161,969.54